Why Eli Lilly Ran Up 7% and How to Trade the Momentum
Eli Lilly jumped about 7% on heavy volume after a string of favorable regulatory and access developments - an EMA positive opinion for Jaypirca and Medicare coverage for its GLP-1 obesity drugs starting 07/01/2026. The move looks tradeable, but the shares are richly valued and technically extended. I lay out a concrete swing trade with entry, stop …